Identification and validation of cell senescence genes in recurrent spontaneous abortion via multiple bioinformatics

Yiyun Wei1,2, Zhuolin Zhou3,4, Changqiang Wei1

  • 1Department of Prenatal Diagnosis and Genetic Diseases Diagnosis, The First Affliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Scientific Reports
|October 10, 2025
PubMed

Insights

Cellular senescence is implicated in recurrent spontaneous abortion (RSA). Researchers identified three key genes (TBX2, SRSF3, TNRC6B) as potential biomarkers for RSA, paving the way for new diagnostic and therapeutic strategies.

Area of Science:

  • Reproductive Medicine
  • Genomics
  • Cellular Biology

Background:

  • Recurrent spontaneous abortion (RSA) affects 5% of couples globally, with limited treatment efficacy.
  • Cellular senescence is increasingly recognized as a factor in various diseases.
  • The role of cellular senescence in RSA pathogenesis requires further investigation.

Purpose of the Study:

  • To identify cellular senescence genes associated with RSA using integrated bioinformatics approaches.
  • To validate the expression of identified genes at the transcriptome and protein levels.
  • To explore the diagnostic and therapeutic potential of these genes in RSA.

Main Methods:

  • Integrated analysis of two RNA sequencing datasets.
  • Weighted Gene Co-Expression Network Analysis (WGCNA) and five machine learning algorithms (XGBoost, Boruta, LASSO, SVM-RFE, Random Forest).
  • Validation using qPCR, Western blot, immunofluorescence, Artificial Neural Network (ANN) modeling, functional enrichment, and single-cell RNA sequencing.

Main Results:

  • Three cellular senescence genes (TBX2, SRSF3, TNRC6B) were identified and found to be upregulated in RSA patients.
  • These genes are involved in MAPK signaling, ECM-receptor interaction, and cell-cell communication.
  • Potential small molecule therapeutics for RSA were identified through drug sensitivity analysis.

Conclusions:

  • Cellular senescence plays a significant role in RSA pathology.
  • TBX2, SRSF3, and TNRC6B are potential diagnostic biomarkers for RSA.
  • This study provides a foundation for developing novel diagnostic and therapeutic strategies for RSA.

Related Concept Videos